Showing results (81-90 of 140) with videos related to
Sort By:
Pageof 14
Oncology|January 1, 1975
The CEA test in urologic cancer: an evaluation and a reviewP Guinan, A Dubin, I Bush, et al.Clinical and Experimental Immunology|October 1, 1979
Modulatory effects of oestrogen on immunological responsiveness. II. Suppression of tumour-associated immunity in patients with prostatic cancerR J Ablin, R A Bhatti, P D Guinan, et al.Journal of Experimental Therapeutics & Oncology|June 8, 2007
Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancerGaynor Davies, Richard J Ablin, Malcolm D Mason, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1994
Antibiotic induced meningitisY River, L Averbuch-Heller, M Weinberger, et al.Oncology|January 1, 1974
Migration-inhibitory effect of serum from patients with prostatic cancerR J Ablin, G R Bruns, P D Guinan, et al.Urologia Internationalis|January 1, 1976
Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. IV. Leucocyte adherence inhibitionR J Ablin, R A Bhatti, P D Guinan, et al.Journal of Translational Medicine|April 29, 2011
Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancerRichard J Ablin, Howard G Kynaston, Malcolm D Mason, et al.Experientia|November 15, 1979
Effect of human seminal plasma on tumour-associated immunity in prostatic cancer. A preliminary reportR J Ablin, R A Bhatti, P D Guinan, et al.Cytotherapy|March 31, 2012
Cell-based therapy for epithelial woundsDavid T Harris, Jianhua Hilgaertner, Caitlin Simonson, et al.Urologia Internationalis|January 1, 1976
Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. I. Thymic-dependent lymphocytic blastogenesisR J Ablin, G R Bruns, P D Guinan, et al.Pageof 14